Skip to main content
IMRN
NASDAQ Life Sciences

Immuron Ltd Announces Resignation of CFO/Company Secretary and Immediate Replacements

Analysis by Wiseek AI
Sentiment info
Neutral
Importance info
7
Price
$0.806
Mkt Cap
$6.869M
52W Low
$0.677
52W High
$2.39
Market data snapshot near publication time

Summary

Immuron Ltd announced the resignation of its long-serving Chief Financial Officer and Company Secretary, Phillip Hains, and the immediate appointment of new executives to both roles.


Key Events

  • CFO and Company Secretary Resignation

    Phillip Hains resigned from both roles, effective February 9, 2026, after serving the company since 2013.

  • New Company Secretary Appointed

    Ms. Olga Smejkalova was appointed as Company Secretary, bringing experience in corporate governance and compliance.

  • New Chief Financial Officer Appointed

    Mr. Aaron Laurita was appointed as Chief Financial Officer, bringing finance and commercial expertise across several sectors.


Analysis

The departure of a long-serving Chief Financial Officer and Company Secretary, Phillip Hains, marks a significant change in Immuron Ltd's executive leadership. While the company immediately appointed Olga Smejkalova as Company Secretary and Aaron Laurita as Chief Financial Officer, investors may scrutinize the reasons for the change and the qualifications of the new appointees, especially for a micro-cap company. This transition comes after recent positive financial news but also a highly dilutive share issuance, adding to the company's evolving corporate landscape.

At the time of this filing, IMRN was trading at $0.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.9M. The 52-week trading range was $0.68 to $2.39. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IMRN - Latest Insights

IMRN
May 07, 2026, 9:40 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.830
Real-time Price: $1.19 info
Change: +$0.360 (+43%) info
Market Cap: $7.827M info
IMRN
Apr 17, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.8045
Real-time Price: $1.19 info
Change: +$0.3855 (+48%) info
Market Cap: $7.827M info
IMRN
Apr 16, 2026, 9:37 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.8045
Real-time Price: $1.19 info
Change: +$0.3855 (+48%) info
Market Cap: $7.827M info
IMRN
Apr 13, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.760
Real-time Price: $1.19 info
Change: +$0.430 (+57%) info
Market Cap: $7.827M info
IMRN
Mar 05, 2026, 8:03 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.746272
Real-time Price: $1.19 info
Change: +$0.443728 (+59%) info
Market Cap: $7.827M info
IMRN
Feb 27, 2026, 9:58 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.8494
Real-time Price: $1.19 info
Change: +$0.3406 (+40%) info
Market Cap: $7.827M info
IMRN
Feb 17, 2026, 8:00 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.730
Real-time Price: $1.19 info
Change: +$0.460 (+63%) info
Market Cap: $7.827M info
IMRN
Feb 12, 2026, 8:00 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.726
Real-time Price: $1.19 info
Change: +$0.464 (+64%) info
Market Cap: $7.827M info
IMRN
Feb 09, 2026, 8:00 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.8058
Real-time Price: $1.19 info
Change: +$0.3842 (+48%) info
Market Cap: $7.827M info
IMRN
Jan 22, 2026, 9:58 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.9706
Real-time Price: $1.19 info
Change: +$0.2194 (+23%) info
Market Cap: $7.827M info